ETadmin, Author at Elevar Therapeutics

Clinical Trial Associate

May 10, 2019

Job Title Clinical Trial Associate (CTA) Job Status Full Time Job Summary The Clinical Trial Associate (CTA) supports at least one primary project, and depending on scope and phase of project, may support multiple projects. The CTA provides support to one or more Clinical

Senior Scientists, Clinical

May 9, 2019

Job Title Senior Scientists, Clinical Job Status Full Time Job Summary The senior clinical scientist will be a key player of a multi-disciplinary, matrix team ensuring that scientific issues are appropriately considered with respect to highly complex clinical data findings. This individual

Principal Medical Writer

May 9, 2019

Job Title Principal Medical Writer Job Status Full Time Job Summary The Principal Medical Writer is responsible for authoring documents, including clinical study reports (CSRs), protocols, investigator’s brochures, publications and other documents. This position is also expected to contribute to higher level submission documents.

Business Development/Safety Project Management Associate

April 22, 2019

Business Development/Safety Project Management Associate. Work within the pharmaceutical industry practices and standards for new drug development and safety reporting. Organize aggregate safety data including adverse events, concomitant medications and lab data. Prepare and lead safety oversight meetings for global

LSK BioPharma and Jiangsu Hengrui Medicine Announce FDA Clearance to Initiate a Phase 3 Clinical Trial in Advanced Hepatocellular Carcinoma (HCC)

April 8, 2019

SALT LAKE CITY, USA, and SHANGHAI, CHINA, April 8, 2019 -- LSK BioPharma (or “LSKB”), a US-based biopharmaceutical firm and Jiangsu Hengrui Medicine, Co., Ltd. (SHA:600276, or “Hengrui”), one of the largest and most innovative fully-integrated biopharmaceutical companies based in

LSKB Announces that the ANGEL Study Has Reached its Primary Completion Date

February 12, 2019

SALT LAKE CITY, USA, Feb 12, 2019 -- LSK BioPharma (LSKB, Company) announced that it has reached the pre-specified number of events required for unblinding and analysis of the primary endpoint of overall survival in the ANGEL study, a global

LSK BioPharma Introduces New Location for Its Corporate Headquarters

February 2, 2019

SALT LAKE CITY, USA, Feb 2nd, 2019 – In order to accommodate rapid growth, LSK BioPharma (LSKB, Company) has relocated its corporate headquarters to 2825 E Cottonwood Pkwy, Suite 180, Salt Lake City, Utah 84121 USA. The new offices will

CMC Senior Director

November 21, 2018

Overview We are currently seeking a full-time, San Francisco office-based CMC Senior Director to join LSK BioPharma. This position will manage and guide our API and CMC activities for our small molecule drug substance and product programs from preclinical through commercial. If

Regulatory Affairs Associate

November 9, 2018

JOB DESCRIPTION Responsible for compliance with applicable procedures. This position will play a key role in preparing US and international regulatory filings. Individual coordinates and supports technical and scientific regulatory activities, researches regulations and guidelines, and maintains and organizes key information

LSKB Announces Completion of Enrollment for the ANGEL Study of Rivoceranib (Apatinib) in Gastric Cancer

October 29, 2018

SALT LAKE CITY, USA, Oct 29th, 2018 -- LSK BioPharma (LSKB, Company) announced that it has completed patient enrollment in its pivotal Phase 3 trial, ANGEL, which is evaluating the efficacy and safety of rivoceranib plus Best Supportive Care (BSC)

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
JSESSIONID	session	The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_J9N59KKZLK	2 years	This cookie is installed by Google Analytics.

Pencil Banner Copy AUGUST2023

Author: ETadmin